Filing Details
- Accession Number:
- 0001225208-10-022519
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-10-08 16:16:33
- Reporting Period:
- 2010-10-06
- Filing Date:
- 2010-10-08
- Accepted Time:
- 2010-10-08 16:16:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 901458 | M Peter Nicholas | One Boston Scientific Place Natick MA 01760-1537 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-10-06 | 25,000 | $6.12 | 5,131,021 | No | 4 | S | Indirect | By Ltd. Partnership |
| Common Stock | Disposition | 2010-10-06 | 50,000 | $0.00 | 5,081,021 | No | 4 | J | Indirect | By Ltd. Partnership |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Ltd. Partnership |
| No | 4 | J | Indirect | By Ltd. Partnership |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Forward Sale Contract (obligation to sell) | Disposition | 2010-10-06 | 50,000 | $0.00 | 50,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-10-06 | 2010-10-06 | No | 4 | J | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 9,212,125 | Direct | |
| Common Stock | 2,413,088 | Indirect | By Trust 2 |
Footnotes
- Sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
- Weighted average sales price reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $6.1602 to $6.11. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
- On August 26, 2009, a family limited partnership of which the reporting person is a general and limited partner, Promerica LP, entered into a Rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. On October 6, 2010, Promerica settled a prepaid variable contract originally entered into on October 6, 2009. At the initiation of the contract, the bank paid $397,136.69 to the reporting person.
- The forward sale contract obligated Promerica to deliver to the bank at maturity up to 50,000 shares of the Issuer's common stock depending on market prices at maturity. If the market price per share at maturity was equal to or less than the floor price of $9.9086 per share, Promerica would deliver 50,000 shares to the bank. If the market price per share at maturity was greater than the floor price, Promerica would deliver a fewer number of shares. The closing market price per share on October 6, 2010 was $6.14. Accordingly, Promerica transferred to the bank 50,000 shares of the Issuer's common stock.
- Shares held by a trust of which the reporting persons spouse and brother are trustees and the reporting person's spouse and children are beneficiaries.
Billionaire Hedge Funds
